A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00009953/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The reason for this long term study is to see how safe and effective the study drug known as
baricitinib is in participants with systemic lupus erythematosus (SLE) who have completed the
final treatment visit of study I4V-MC-JAHZ (NCT03616912) or study I4V-MC-JAIA (NCT03616964).
提供机构：
Vivli
创建时间：
2024-04-03
